相关实验视频
Updated: Jun 27, 2025

06:47
Microfluidics in Assessing Platelet Function
Published on: November 8, 2024
842
生物巨分子的进步 静血材料:一篇综述
Mengyang Zhang1, Feng Han1, Xunxin Duan1
1Clinical Medical College/Affiliated Hospital of Jiujiang University, Jiujiang, Jiangxi, China; Jiujiang Clinical Precision Medicine Research Center, Jiujiang, Jiangxi, China.
International journal of biological macromolecules
|April 26, 2024
概括
基于聚合物的静血材料提供卓越的生物相容性和粘附性,有效控制出血,最大限度地减少进一步的组织损伤. 本综述探讨了天然,合成和复合聚合物血静性材料的进展.
科学领域:
- 生物材料科学 生物材料科学
- 聚合物化学 聚合物化学
- 血液静止研究 血液静止研究
背景情况:
- 传统的静血剂可能会由于粘附性差导致二次损伤.
- 聚合物基材料具有增强的生物相容性和有效控制出血.
- 最近的创新重点是针对特定器官应用的功能化聚合物血静止剂.
研究的目的:
- 审查聚合物血静性材料的最新进展.
- 讨论各种聚合物类型的机制,优点和缺点.
- 突出设计策略,特性,表征和特定器官的应用.
主要方法:
- 关于聚合物血静性材料的最新研究的文献综述.
- 凝血级联和静血机制的分析.
- 对天然,合成和复合聚合物血静止剂的检查.
主要成果:
- 聚合物血静止剂表现出比传统材料更好的粘附性和生物相容性.
- 不同的设计策略产生了针对目标血液静止的功能化材料.
- 记录了各种器官的成功应用,展示了材料的多功能性.
结论:
- 聚合物血静性材料在血液管理方面取得了重大进展.
- 对设计,表征和应用的进一步研究有望改善临床结果.
- 本综述为该领域的未来发展提供了全面的参考.
相关概念视频
Anticoagulant Drugs: Low-Molecular-Weight Heparins
687
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
687
Introduction to Hemostasis
7.4K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
7.4K
Extrinsic and Intrinsic Pathways of Hemostasis
7.3K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
7.3K
Formation of the Platelet Plug
6.0K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
6.0K
Coagulation
6.4K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
6.4K
Disorders of Hemostasis
872
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
872

